Product NDC: | 59767-016 |
Proprietary Name: | PERTZYE |
Non Proprietary Name: | pancrelipase |
Active Ingredient(s): | 60500; 16000; 57500 [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp; pancrelipase |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59767-016 |
Labeler Name: | Digestive Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022175 |
Marketing Category: | NDA |
Start Marketing Date: | 20120517 |
Package NDC: | 59767-016-02 |
Package Description: | 1 BOTTLE in 1 CARTON (59767-016-02) > 250 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
NDC Code | 59767-016-02 |
Proprietary Name | PERTZYE |
Package Description | 1 BOTTLE in 1 CARTON (59767-016-02) > 250 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
Product NDC | 59767-016 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pancrelipase |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120517 |
Marketing Category Name | NDA |
Labeler Name | Digestive Care, Inc. |
Substance Name | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
Strength Number | 60500; 16000; 57500 |
Strength Unit | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
Pharmaceutical Classes |